PCRF: Emerging Investigator Fellowship Grant

The Pediatric Cancer Research Foundation (PCRF) offers the Emerging Investigator Fellowship Grant to support post-doctoral fellowships and clinical investigator training for promising pediatric cancer researchers. This grant aims to accelerate advancements in childhood cancer treatment by funding innovative research ideas. Applicants must have completed a minimum of two years in their fellowship or be within two years of their junior faculty role. This initiative fosters the next generation of researchers dedicated to combating childhood cancer.

NOTE: A Letter of Intent is required in order to be invited to submit a grant application.
Background
At PCRF, we are unique in our approach to funding childhood cancer research — working directly with doctors, researchers, and nurses to identify the specific challenges they face in bringing new treatments to and caring for children with cancer. Our careful distribution of grants has allowed doctors and nurses to speed up the process of bringing the latest and most promising life-saving treatments to seriously ill children. The result is bringing hope to childhood cancer patients now and in the future.
PCRF is an equal opportunity organization.No one is excluded from employment, membership on our governing body, or research support because of race, religion, sex, national origin, age or physical handicap.
No infrastructure or support services will be funded.
These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future.

Eligibility

PCRF awards grants annually to extraordinary researchers offering the best hope for a cure to childhood cancer.
Grant Criteria:

• The probability of an advance in prevention, diagnosis or treatment for the near-term
• The novelty of the concept and strategy
• The clarity of presentation
• The overall plan for bringing the research findings to clinical application
• Experience, background, and qualifications of the investigators
• Adequacy of resources and environment (Facilities, patients, etc.)

Funds awarded shall be used solely for the purposes specified in the application submitted for consideration and in strict compliance with the budget submitted with the application.
PCRF is not responsible if for any reason funds are expended at an amount in excess of the awarded Grant amount.
It will be the responsibility of the sponsoring institution to make restitution to PCRF for any remaining funds in the event of transfer or premature termination of the grant.
If a Primary Investigator grantee transfers or terminates from his sponsoring institution during the course of the Grant award period, the Grant will immediately terminate, and can be only be transferred to another institution with the written approval of PCRF’s Scientific Committee and Board of Directors.
Should the Grantee sell, license, or transfer the technology or intellectual property developed under this Grant, PCRF shall be entitled to 30% of the compensation paid to the Grantee organization as a result of the sale, license, or transfer.
The designation “Supported by a research grant from the Pediatric Cancer Research Foundation” shall be used in all related research publications during the period of the grant.
“Support by the Pediatric Cancer Research Foundation” should also be stated in any news releases about the grantee or grantee’s project by the public relations department or its equivalent at the sponsoring institution.
In the event the grantee desires to transfer to another institution while the grant is in effect, continuation of the funding at the new institution may be allowed with the prior written approval of PCRF’s Scientific Committee and Board of Directors.
To obtain permission for relocation, the grantee must request a transfer from PCRF 30 days prior to the projected move.
The decision to approve the transfer will be at the sole discretion of PCRF and will be dependent upon several factors including acceptance by the new sponsoring institution and convincing evidence that the new environment and collaborations will permit successful pursuit of the research.
A final accounting of all disbursements of the Grant funds by the original institution through the proposed day of transfer will also be required.
All grantees will be required to submit periodic progress reports as defined in the Letter of Agreement.

Ineligibility

No indirect costs will be funded.